Apreo Health, a clinical-stage medical device company pioneering a novel, tissue-sparing approach for treating severe emphysema, today announced the presentation of new data in three oral sessions at ...

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European ...

Apreo Health today announced positive study results for its novel, self-expanding Breathe nitinol airway scaffold.

Collectively, these findings provide the rationale and foundation for the innovative adaptive design of AdvanCell’s ongoing Phase 1b/2 TheraPb trial of ADVC001 (NCT05720130), the Company’s ...

Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest improvements observed in those with elevated baseline levels of key type 2 ...

Aerobic exercise may promote myelin repair in some parts of the brain in people with multiple sclerosis (MS), according to a ...

There are clear benefits to starting biologic therapy earlier for severe asthma, as well as initiation patterns by ethnicity, ...

Natural language processing (NLP) algorithms can identify a subgroup of children with asthma who have a high risk for acute ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...

From automotive plants to hospitals, banks, and burger chains, organisations are investing billions to insert AI into every ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

The future lies in human-centric supercomputing, systems that deliver immense computational power through intuitive, secure ...